Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AN2 Therapeutics, Inc. - Common Stock (NQ: ANTX )

10.84 +1.08 (+11.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AN2 Therapeutics, Inc. - Common Stock

< Previous 1 2 Next >
AN2 Therapeutics to Participate in Upcoming Investor Conferences
From AN2 Therapeutics, Inc.
Via Business Wire
AN2 Therapeutics to Present at SVB Securities Global Biopharma Conference
From AN2 Therapeutics, Inc.
Via Business Wire
Top 5 Health Care Stocks That May Dip
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Lennar To Rally Around 14%? Plus Keybanc Predicts $5,120 For This Stock
  Keybanc boosted the price target on Lennar Corporation (NYSE: LEN) from $89 to $100. Lennar shares fell 0.4% to close at $88.03 on Friday. 
Via Benzinga
AN2 Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
From AN2 Therapeutics, Inc.
Via Globe NewsWire
AN2 Therapeutics to Present at Upcoming Investor Conferences
From AN2 Therapeutics, Inc.
Via Globe NewsWire
AN2 Therapeutics to Present New Epetraborole Data at IDWeek 2022
From AN2 Therapeutics, Inc.
Via Globe NewsWire
Uber, Lyft, AZZ And Other Big Losers From Tuesday
U.S. stocks closed mixed with the Nasdaq Composite dropping more than 100 points on Tuesday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday. 
Via Benzinga
AN2 Therapeutics Provides Update on Epetraborole Ex-U.S. Development Plan in Treatment-Refractory MAC Lung Disease
From AN2 Therapeutics, Inc.
Via Globe NewsWire
NIH Awards Contract to AN2 Therapeutics Valued Up to $17.8 Million
NIAID Agreement to Advance Development of Epetraborole for Acute Systemic Melioidosis 
From AN2 Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
  
Via Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility. 
Via Benzinga
Nasdaq Drops 200 Points; American Woodmark Shares Spike Higher
U.S. stocks extended losses toward the end of trading, with the Nasdaq Composite dropping around 200 points on Tuesday 
Via Benzinga
How Is The Market Feeling About AN2 Therapeutics?
AN2 Therapeutics (NASDAQ:ANTX) short percent of float has risen 4.76% since its last report. The company recently reported that it has 194 thousand shares sold short,... 
Via Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year. 
Via Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. 
Via Benzinga
LegalZoom.com, Toast And Some Other Big Stocks Moving Higher On Friday
  WeTrade Group, Inc. (NASDAQ: WETG) jumped 46% to $20.56 after the company announced it entered into a sales agreement with Parkway Medical Limited to sell monkeypox virus test kits and antigen tests... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Conformis (NASDAQ:CFMS) shares moved upwards by 13.2% to $0.29 during Monday's after-market session. The company's market cap stands at $53.5 million. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Good morning, investors! We're back at it this week with a breakdown of the biggest pre-market stock movers to watch on Monday! 
Via InvestorPlace
Boeing And 24 Stocks Moving Premarket
Gainers Qudian Inc. (NYSE: QD) rose 61.3% to $1.92 in pre-market trading after the company issued an update on its QD Food ready-to-cook meal business. 
Via Benzinga
89 Biggest Movers From Friday
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. 
Via Benzinga
79 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
81 Biggest Movers From Yesterday
Gainers Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results. 
Via Benzinga
AN2 Therapeutics Appoints Maggie FitzPatrick to Its Board of Directors
From AN2 Therapeutics, Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.